• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/14/2023
Event Type  malfunction  
Manufacturer Narrative
Section e3: occupation is patient/consumer.The meter and test strips were requested for investigation.The meter and test strips were provided for investigation.An e-62 error message was observed on the returned meter.This error is related to a temperature or heater error.The returned test strips were tested with a retention meter and retention controls.Testing results (qc range = 2.3 - 3.5 inr): qc 1: 3.0 inr, qc 2: 2.9 inr, qc 3: 2.9 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.The alleged result of 2.7 inr on (b)(6) 2023 was not observed in the meter¿s patient result memory.The alleged result of 2.6 inr on 14-oct-2023 was not observed in the meter¿s patient result memory.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." the investigation is ongoing.
 
Event Description
There was an allegation of discrepant inr results with a coaguchek vantus meter compared to an unknown laboratory method.On 14-oct-2023 the result from the meter was reportedly 2.6 inr.The result from an unknown laboratory method within 4 hours was reportedly 1.6 inr.On (b)(6) 2023 the result from the meter was 1.7 inr.The result from an unknown laboratory method within 4 hours was reportedly "in the low 2.0¿s inr." the specific result was not provided.On (b)(6) 2023 the result from the meter was 1.7 inr.The result from an unknown laboratory method within 4 hours was reportedly "in the low 2.0¿s inr." the specific result was not provided.On (b)(6) 2023 the result from the meter was reportedly 2.7 inr.The result from an unknown laboratory method within 4 hours was reportedly "in the low 2.0¿s inr." the specific result was not provided.The patient¿s therapeutic range is reportedly 2.0 ¿ 3.0 inr with an alleged testing frequency of twice a month.
 
Manufacturer Narrative
The meter was investigated further due to the e-62 error message.The circuit board and heater were checked for contamination or damage.The investigation identified a defective heating coil.The returned test strips worked as specified.The e-62 error message was due to the defective heating coil.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key18187977
MDR Text Key328984450
Report Number1823260-2023-03742
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 01/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/30/2024
Device Catalogue Number04625374160
Device Lot Number65031624
Was Device Available for Evaluation? Device Returned to Manufacturer
Initial Date Manufacturer Received 10/26/2023
Initial Date FDA Received11/21/2023
Supplement Dates Manufacturer Received01/17/2024
Supplement Dates FDA Received01/23/2024
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AMOXICILLIN; ATORVASTATIN; BABY ASPIRIN; GLUCOSAMINE CHONDROITIN; LOSARTAN; SR MULTIPLE VITAMIN; WARFARIN
Patient Age68 YR
Patient SexMale
-
-